annual EBITDA:
-$313.91M+$131.23M(+29.48%)Summary
- As of today (May 29, 2025), ASND annual EBITDA is -$313.91 million, with the most recent change of +$131.23 million (+29.48%) on December 31, 2024.
- During the last 3 years, ASND annual EBITDA has risen by +$117.53 million (+27.24%).
- ASND annual EBITDA is now -4718.17% below its all-time high of $6.80 million, reached on December 31, 2013.
Performance
ASND EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$51.33M-$10.93M(-27.07%)Summary
- As of today (May 29, 2025), ASND quarterly EBITDA is -$51.33 million, with the most recent change of -$10.93 million (-27.07%) on March 31, 2025.
- Over the past year, ASND quarterly EBITDA has dropped by -$396.20 thousand (-0.78%).
- ASND quarterly EBITDA is now -2283.19% below its all-time high of $2.35 million, reached on December 31, 2013.
Performance
ASND quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$266.35M-$396.20K(-0.15%)Summary
- As of today (May 29, 2025), ASND TTM EBITDA is -$266.35 million, with the most recent change of -$396.20 thousand (-0.15%) on March 31, 2025.
- Over the past year, ASND TTM EBITDA has increased by +$119.18 million (+30.91%).
- ASND TTM EBITDA is now -11429.03% below its all-time high of $2.35 million, reached on December 31, 2013.
Performance
ASND TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ASND EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +29.5% | -0.8% | +30.9% |
| 3 y3 years | +27.2% | +60.4% | +44.1% |
| 5 y5 years | -33.3% | +23.7% | -13.8% |
ASND EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +43.8% | -27.1% | +73.9% | -0.1% | +52.5% |
| 5 y | 5-year | -33.3% | +43.8% | -27.1% | +75.3% | -13.8% | +52.5% |
| alltime | all time | -4718.2% | +43.8% | -2283.2% | +75.3% | <-9999.0% | +52.5% |
ASND EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$51.33M(+27.1%) | -$266.35M(+0.1%) |
| Dec 2024 | -$313.91M(-29.5%) | -$40.39M(-48.4%) | -$265.95M(-10.9%) |
| Sep 2024 | - | -$78.23M(-18.8%) | -$298.45M(-18.1%) |
| Jun 2024 | - | -$96.40M(+89.3%) | -$364.28M(-5.5%) |
| Mar 2024 | - | -$50.93M(-30.1%) | -$385.53M(-11.8%) |
| Dec 2023 | -$445.13M(-20.2%) | -$72.89M(-49.4%) | -$436.88M(-22.0%) |
| Sep 2023 | - | -$144.06M(+22.5%) | -$560.44M(+3.7%) |
| Jun 2023 | - | -$117.64M(+15.0%) | -$540.65M(+9.2%) |
| Mar 2023 | - | -$102.28M(-47.9%) | -$494.95M(-5.2%) |
| Dec 2022 | -$558.07M(+29.4%) | -$196.46M(+58.1%) | -$522.21M(+18.5%) |
| Sep 2022 | - | -$124.27M(+72.7%) | -$440.78M(+8.6%) |
| Jun 2022 | - | -$71.94M(-44.5%) | -$405.74M(-14.9%) |
| Mar 2022 | - | -$129.54M(+12.6%) | -$476.83M(+14.2%) |
| Dec 2021 | -$431.44M(-7.4%) | -$115.02M(+28.9%) | -$417.66M(-18.2%) |
| Sep 2021 | - | -$89.23M(-37.6%) | -$510.66M(-0.7%) |
| Jun 2021 | - | -$143.03M(+103.2%) | -$514.42M(+11.3%) |
| Mar 2021 | - | -$70.37M(-66.2%) | -$462.29M(+0.7%) |
| Dec 2020 | -$465.73M(+97.8%) | -$208.02M(+123.7%) | -$459.19M(+36.0%) |
| Sep 2020 | - | -$92.99M(+2.3%) | -$337.56M(+25.0%) |
| Jun 2020 | - | -$90.91M(+35.2%) | -$270.02M(+15.3%) |
| Mar 2020 | - | -$67.27M(-22.1%) | -$234.12M(+3.5%) |
| Dec 2019 | -$235.48M | -$86.39M(+239.4%) | -$226.17M(+28.5%) |
| Sep 2019 | - | -$25.45M(-53.7%) | -$176.00M(-7.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | -$55.01M(-7.3%) | -$189.84M(+17.3%) |
| Mar 2019 | - | -$59.32M(+63.8%) | -$161.89M(+11.9%) |
| Dec 2018 | -$152.90M(+9.3%) | -$36.22M(-7.8%) | -$144.68M(-10.3%) |
| Sep 2018 | - | -$39.29M(+45.1%) | -$161.26M(+1.7%) |
| Jun 2018 | - | -$27.07M(-35.7%) | -$158.55M(+0.2%) |
| Mar 2018 | - | -$42.11M(-20.2%) | -$158.25M(+12.3%) |
| Dec 2017 | -$139.91M(+85.8%) | -$52.79M(+44.3%) | -$140.93M(+29.3%) |
| Sep 2017 | - | -$36.59M(+36.7%) | -$109.02M(+18.1%) |
| Jun 2017 | - | -$26.77M(+8.0%) | -$92.30M(+14.8%) |
| Mar 2017 | - | -$24.78M(+18.7%) | -$80.42M(+7.0%) |
| Dec 2016 | -$75.32M(+105.6%) | -$20.88M(+5.2%) | -$75.18M(+6.6%) |
| Sep 2016 | - | -$19.86M(+33.3%) | -$70.56M(+20.6%) |
| Jun 2016 | - | -$14.90M(-23.7%) | -$58.53M(+1.5%) |
| Mar 2016 | - | -$19.54M(+20.1%) | -$57.66M(+58.8%) |
| Dec 2015 | -$36.63M(+180.5%) | -$16.26M(+107.7%) | -$36.32M(+33.3%) |
| Sep 2015 | - | -$7.83M(-44.2%) | -$27.25M(+25.2%) |
| Jun 2015 | - | -$14.03M(-877.4%) | -$21.76M(+109.1%) |
| Mar 2015 | - | $1.81M(-125.1%) | -$10.41M(-17.9%) |
| Dec 2014 | -$13.06M(-292.1%) | -$7.19M(+206.4%) | -$12.68M(+303.4%) |
| Sep 2014 | - | -$2.35M(-12.4%) | -$3.14M(+294.1%) |
| Jun 2014 | - | -$2.68M(+470.0%) | -$797.50K(-142.4%) |
| Mar 2014 | - | -$469.90K(-120.0%) | $1.88M(-20.0%) |
| Dec 2013 | $6.80M(+205.6%) | $2.35M | $2.35M |
| Dec 2012 | $2.22M | - | - |
FAQ
- What is Ascendis Pharma A/S annual EBITDA?
- What is the all time high annual EBITDA for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S annual EBITDA year-on-year change?
- What is Ascendis Pharma A/S quarterly EBITDA?
- What is the all time high quarterly EBITDA for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S quarterly EBITDA year-on-year change?
- What is Ascendis Pharma A/S TTM EBITDA?
- What is the all time high TTM EBITDA for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S TTM EBITDA year-on-year change?
What is Ascendis Pharma A/S annual EBITDA?
The current annual EBITDA of ASND is -$313.91M
What is the all time high annual EBITDA for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high annual EBITDA is $6.80M
What is Ascendis Pharma A/S annual EBITDA year-on-year change?
Over the past year, ASND annual EBITDA has changed by +$131.23M (+29.48%)
What is Ascendis Pharma A/S quarterly EBITDA?
The current quarterly EBITDA of ASND is -$51.33M
What is the all time high quarterly EBITDA for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high quarterly EBITDA is $2.35M
What is Ascendis Pharma A/S quarterly EBITDA year-on-year change?
Over the past year, ASND quarterly EBITDA has changed by -$396.20K (-0.78%)
What is Ascendis Pharma A/S TTM EBITDA?
The current TTM EBITDA of ASND is -$266.35M
What is the all time high TTM EBITDA for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high TTM EBITDA is $2.35M
What is Ascendis Pharma A/S TTM EBITDA year-on-year change?
Over the past year, ASND TTM EBITDA has changed by +$119.18M (+30.91%)